{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:56:18Z","timestamp":1790427378548,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"ITMO Cancer AVIESAN"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40271-024-00687-6","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T18:02:07Z","timestamp":1714586527000},"page":"575-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimizing Communication on HPV Vaccination to Parents of 11- to 14-Year-Old Adolescents in France: A Discrete Choice Experiment"],"prefix":"10.1007","volume":"17","author":[{"given":"Sandra","family":"Chyderiotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sicsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Gagneux-Brunon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Raude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Barret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Gauchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Le Duc Banaszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Giraudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Thilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0797-9971","authenticated-orcid":false,"given":"Judith E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the PrevHPV Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"687_CR1","first-page":"645","volume":"97","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Human papillomavirus vaccines: WHO position paper. Wkly Epidemiol Rec. 2022;97:645\u201372.","journal-title":"Wkly Epidemiol Rec"},{"key":"687_CR2","unstructured":"Sant\u00e9 Publique France. Donn\u00e9es de couverture vaccinale papillomavirus humains (HPV) par groupe d\u2019\u00e2ge. 2022. https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/articles\/donnees-de-couverture-vaccinale-papillomavirus-humains-hpv-par-groupe-d-age. Accessed 31 Aug 2023."},{"key":"687_CR3","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/21645515.2018.1564436","volume":"15","author":"E Karafillakis","year":"2019","unstructured":"Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019;15:1615\u201327. https:\/\/doi.org\/10.1080\/21645515.2018.1564436.","journal-title":"Hum Vaccin Immunother"},{"key":"687_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ypmed.2018.12.014","volume":"120","author":"J Wang","year":"2019","unstructured":"Wang J, Ploner A, Spar\u00e9n P, Lepp T, Roth A, Arnheim-Dahlstr\u00f6m L, et al. Mode of HPV vaccination delivery and equity in vaccine uptake: a nationwide cohort study. Prev Med. 2019;120:26\u201333. https:\/\/doi.org\/10.1016\/j.ypmed.2018.12.014.","journal-title":"Prev Med"},{"key":"687_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019206","volume":"8","author":"PA Newman","year":"2018","unstructured":"Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, et al. Parents\u2019 uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018;8: e019206. https:\/\/doi.org\/10.1136\/bmjopen-2017-019206.","journal-title":"BMJ Open"},{"key":"687_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. https:\/\/doi.org\/10.1186\/1748-5908-6-42.","journal-title":"Implement Sci"},{"key":"687_CR7","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1016\/j.vaccine.2015.04.039","volume":"33","author":"GJ Nowak","year":"2015","unstructured":"Nowak GJ, Gellin BG, MacDonald NE, Butler R, Eskola J, Liang X, et al. Addressing vaccine hesitancy: the potential value of commercial and social marketing principles and practices. Vaccine. 2015;33:4204\u201311. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.039.","journal-title":"Vaccine"},{"key":"687_CR8","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1016\/j.vaccine.2015.04.042","volume":"33","author":"S Goldstein","year":"2015","unstructured":"Goldstein S, MacDonald NE, Guirguis S, Eskola J, Liang X, Chaudhuri M, et al. Health communication and vaccine hesitancy. Vaccine. 2015;33:4212\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.042.","journal-title":"Vaccine"},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"e835","DOI":"10.1542\/peds.2013-2365","volume":"133","author":"B Nyhan","year":"2014","unstructured":"Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion: a randomized trial. Pediatrics. 2014;133:e835\u201342. https:\/\/doi.org\/10.1542\/peds.2013-2365.","journal-title":"Pediatrics"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0266666914527412","volume":"30","author":"MA Bekalu","year":"2014","unstructured":"Bekalu MA. Communication inequalities and health disparities. Inf Dev. 2014;30:189\u201391. https:\/\/doi.org\/10.1177\/0266666914527412.","journal-title":"Inf Dev"},{"key":"687_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/S12879-021-06398-9","author":"ME Diks","year":"2021","unstructured":"Diks ME, Hiligsmann M, van der Putten IM. Vaccine preferences driving vaccine-decision making of different target groups: a systematic review of choice-based experiments. BMC Infect Dis. 2021. https:\/\/doi.org\/10.1186\/S12879-021-06398-9.","journal-title":"BMC Infect Dis"},{"key":"687_CR12","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1016\/j.vaccine.2020.08.078","volume":"38","author":"A Lack","year":"2020","unstructured":"Lack A, Hiligsmann M, Bloem P, T\u00fcnne\u00dfen M, Hutubessy R. Parent, provider and vaccinee preferences for HPV vaccination: a systematic review of discrete choice experiments. Vaccine. 2020;38:7226\u201338. https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.078.","journal-title":"Vaccine"},{"key":"687_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057943","volume":"12","author":"A Bocquier","year":"2022","unstructured":"Bocquier A, Michel M, Giraudeau B, Bonnay S, Gagneux-Brunon A, Gauchet A, et al. Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study). BMJ Open. 2022;12: e057943. https:\/\/doi.org\/10.1136\/bmjopen-2021-057943.","journal-title":"BMJ Open"},{"key":"687_CR14","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1016\/j.vaccine.2021.05.061","volume":"39","author":"S Chyderiotis","year":"2021","unstructured":"Chyderiotis S, Sicsic J, Raude J, Bonmarin I, Jeanleboeuf F, Banaszuk LD, et al. Optimising HPV vaccination communication to adolescents: a discrete choice experiment. Vaccine. 2021;39:3916\u201325. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.061.","journal-title":"Vaccine"},{"key":"687_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/hec.1369","volume":"18","author":"M Ryan","year":"2009","unstructured":"Ryan M, Watson V, Entwistle V. Rationalising the \u2018irrational\u2019: a think aloud study of discrete choice experiment responses. Health Econ. 2009;18:321\u201336. https:\/\/doi.org\/10.1002\/hec.1369.","journal-title":"Health Econ"},{"key":"687_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4124","author":"C Mansfield","year":"2020","unstructured":"Mansfield C, Sutphin J, Boeri M. Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow-up question. Health Econ. 2020. https:\/\/doi.org\/10.1002\/hec.4124.","journal-title":"Health Econ"},{"issue":"14","key":"687_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"2011","author":"JFP Bridges","year":"2011","unstructured":"Bridges JFP, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health\u2014a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;2011(14):403\u201313. https:\/\/doi.org\/10.1016\/j.jval.2010.11.013.","journal-title":"Value Health"},{"key":"687_CR18","doi-asserted-by":"publisher","first-page":"101058","DOI":"10.1016\/j.ssmph.2022.101058","volume":"17","author":"S Chyderiotis","year":"2022","unstructured":"Chyderiotis S, Sicsic J, Thilly N, Mueller JE. For the PrevHPV consortium. Vaccine eagerness: a new framework to analyse preferences in single profile discrete choice experiments. Application to HPV vaccination decisions among French adolescents. SSM Popul Health. 2022;17:101058. https:\/\/doi.org\/10.1016\/j.ssmph.2022.101058.","journal-title":"SSM Popul Health."},{"key":"687_CR19","unstructured":"Institut national de la statistique et des \u00e9tudes \u00e9conomiques. D\u00e9mographie\u2014France, portrait social, \u00e9dition 2020. 2020. https:\/\/www.insee.fr\/fr\/statistiques\/4797574?sommaire=4928952. Accessed 30 Apr 2023."},{"key":"687_CR20","unstructured":"Beauchemin C, Hamel C, Simon P. Trajectoires et Origines. Enqu\u00eate sur la diversit\u00e9 des populations en France. Premiers r\u00e9sultats. 2020. https:\/\/www.insee.fr\/fr\/information\/4172158. Accessed 27 Oct 2023."},{"key":"687_CR21","first-page":"446","volume":"24\u201325","author":"R Hanguehard","year":"2022","unstructured":"Hanguehard R, Gautier A, Soullier N, Barret AS, Parent du Chatelet I, Vaux S. Couverture vaccinale contre les infections \u00e0 papillomavirus humain des filles \u00e2g\u00e9es de 15 \u00e0 18 ans et d\u00e9terminants de vaccination, France, 2021. Bull Epid\u00e9miol Hebd. 2022;24\u201325:446\u201355.","journal-title":"Bull Epid\u00e9miol Hebd."},{"key":"687_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.socscimed.2019.03.025","volume":"228","author":"J Luyten","year":"2019","unstructured":"Luyten J, Kessels R, Atkins KE, Jit M, van Hoek AJ. Quantifying the public\u2019s view on social value judgments in vaccine decision-making: a discrete choice experiment. Soc Sci Med. 2019;228:181\u201393. https:\/\/doi.org\/10.1016\/j.socscimed.2019.03.025.","journal-title":"Soc Sci Med"},{"key":"687_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181640","volume":"12","author":"S Pluviano","year":"2017","unstructured":"Pluviano S, Watt C, Della SS. Misinformation lingers in memory: failure of three pro-vaccination strategies. PLoS ONE. 2017;12: e0181640. https:\/\/doi.org\/10.1371\/journal.pone.0181640.","journal-title":"PLoS ONE"},{"key":"687_CR24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1158\/1055-9965.EPI-17-1067","volume":"27","author":"MB Gilkey","year":"2018","unstructured":"Gilkey MB, Zhou M, McRee AL, Kornides ML, Bridges JFP. Parents\u2019 views on the best and worst reasons for guideline-consistent HPV vaccination. Cancer Epidemiol Biomark Prev. 2018;27:762\u20137. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-1067.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"687_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/sti.2009.041392","volume":"87","author":"B Oteng","year":"2011","unstructured":"Oteng B, Marra F, Lynd LD, Ogilvie G, Patrick D, Marra CA. Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. Sex Transm Infect. 2011;87:52\u20137. https:\/\/doi.org\/10.1136\/sti.2009.041392.","journal-title":"Sex Transm Infect."},{"issue":"10","key":"687_CR26","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1136\/bmjopen-2021-055148","volume":"11","author":"C D\u00edaz Lu\u00e9vano","year":"2021","unstructured":"D\u00edaz Lu\u00e9vano C, Sicsic J, Pellissier G, Chyderiotis S, Arwidson P, Olivier C, et al. Quantifying healthcare and welfare sector workers\u2019 preferences around COVID-19 vaccination: a cross-sectional, single-profile discrete-choice experiment in France. BMJ Open. 2021;11(10):2021. https:\/\/doi.org\/10.1136\/bmjopen-2021-055148.","journal-title":"BMJ Open"},{"key":"687_CR27","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1016\/j.vaccine.2017.03.086","volume":"35","author":"J Seanehia","year":"2017","unstructured":"Seanehia J, Treibich C, Holmberg C, M\u00fcller-Nordhorn J, Casin V, Raude J, et al. Quantifying population preferences around vaccination against severe but rare diseases: a conjoint analysis among French university students, 2016. Vaccine. 2017;35:2676\u201384. https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.086.","journal-title":"Vaccine"},{"key":"687_CR28","first-page":"209","volume":"97","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Understanding the behavioural and social drivers of vaccine uptake WHO position paper\u2014May 2022. Wkly Epidemiol Rec. 2022;97:209\u201324.","journal-title":"Wkly Epidemiol Rec"},{"key":"687_CR29","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","volume":"383","author":"J Lei","year":"2020","unstructured":"Lei J, Ploner A, Elfstr\u00f6m KM, Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383:1340\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1917338.","journal-title":"N Engl J Med"},{"key":"687_CR30","unstructured":"Anonymous. Prescrire en Questions: Vaccin papillomavirus \u00e0 9 valences\u202f: un progr\u00e8s ignor\u00e9\u202f? Revue Prescrire. 2019;39:468-71. https:\/\/prescrire.org\/Fr\/3\/31\/57333\/0\/NewsDetails.aspx. Accessed 23 Apr 2023."},{"key":"687_CR31","doi-asserted-by":"publisher","DOI":"10.2196\/15899","volume":"22","author":"RB B\u00fcchter","year":"2020","unstructured":"B\u00fcchter RB, Betsch C, Ehrlich M, Fechtelpeter D, Grouven U, Keller S, et al. Communicating uncertainty in written consumer health information to the public: parallel-group, web-based randomized controlled trial. J Med Internet Res. 2020;22: e15899. https:\/\/doi.org\/10.2196\/15899.","journal-title":"J Med Internet Res"},{"key":"687_CR32","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1016\/j.vaccine.2015.04.038","volume":"33","author":"R Butler","year":"2015","unstructured":"Butler R, MacDonald NE, Eskola J, Liang X, Chaudhuri M, Dube E, et al. Diagnosing the determinants of vaccine hesitancy in specific subgroups: the guide to Tailoring Immunization Programmes (TIP). Vaccine. 2015;33:4176\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.038.","journal-title":"Vaccine"},{"key":"687_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ogrm.2015.06.001","volume":"25","author":"SMC Cook","year":"2015","unstructured":"Cook SMC, Cameron ST. Social issues of teenage pregnancy. Obstet Gynaecol Reprod Med. 2015;25:243\u20138. https:\/\/doi.org\/10.1016\/j.ogrm.2015.06.001.","journal-title":"Obstet Gynaecol Reprod Med"},{"key":"687_CR34","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/j.vaccine.2023.08.062","volume":"41","author":"S Vaux","year":"2023","unstructured":"Vaux S, Gautier A, Nassany O, Bonmarin I. Vaccination acceptability in the French general population and related determinants, 2000\u20132021. Vaccine. 2023;41:6281\u201390. https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.062.","journal-title":"Vaccine"},{"key":"687_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112736","volume":"246","author":"EW de Bekker-Grob","year":"2020","unstructured":"de Bekker-Grob EW, Donkers B, Bliemer MCJ, Veldwijk J, Swait JD. Can healthcare choice be predicted using stated preference data? Soc Sci Med. 2020;246: 112736. https:\/\/doi.org\/10.1016\/j.socscimed.2019.112736.","journal-title":"Soc Sci Med"},{"key":"687_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/J.PVR.2017.03.002","volume":"3","author":"LK Petersen","year":"2017","unstructured":"Petersen LK, Restrepo J, Moreira ED, Iversen OE, Pitisuttithum P, Van Damme P, et al. Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine\u2014a combined analysis of five phase III clinical trials. Papillomavirus Res. 2017;3:105\u201315. https:\/\/doi.org\/10.1016\/J.PVR.2017.03.002.","journal-title":"Papillomavirus Res."}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-024-00687-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-024-00687-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-024-00687-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:20:05Z","timestamp":1724455205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-024-00687-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1007\/s40271-024-00687-6","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"assertion":[{"value":"3 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests with regard to the content of this article. The PrevHPV study is conducted with the support of Institut de recherche en sant\u00e9 Publique (IReSP) and Institut national de la sant\u00e9 et de la recherche m\u00e9dicale (Inserm), and with financial support from ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sant\u00e9\/ National Alliance for Life Sciences & Health) within the framework of the Cancer Plan. ITMO Cancer AVIESAN had no role in the collection, analysis, and interpretation of data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest statement\/Funding"}},{"value":"The PrevHPV project was granted approval by Evaluation Committee of Inserm, the Institutional Review Board (IRB00003888, IORG0003254, FWA00005831) on 10 December 2019. All study participants consented to participate after reading the study information. Participants could refuse or stop their participation at any time.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Research data of this article can be made accessible upon reasonable request to the corresponding author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing"}},{"value":"Conceptualization (SC, JS, JEM, JR, ASB); Data curation (SC); Formal analysis (SC, JEM); Funding acquisition (AGB, SB, AG, ASLDB, NT, JEM); Investigation (SC, AGB, AG, ASLDB, NT, JEM); Methodology (SC, JS, MM, BG, JEM); Validation (all authors); Writing \u2013 original draft (SC); and Writing \u2013 review & editing (all authors).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"All study participants consented to participate after reading the study information. Participants could refuse or stop their participation at any time.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All co-authors approved the final version of the manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Research data and codes of this article can be made accessible upon reasonable request to the corresponding author.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}